FluoroPharma Medical, Inc. (FPMI)
FPMI Stock Price Chart
Explore FluoroPharma Medical, Inc. interactive price chart. Choose custom timeframes to analyze FPMI price movements and trends.
FPMI Company Profile
Discover essential business fundamentals and corporate details for FluoroPharma Medical, Inc. (FPMI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 May 2011
Employees
4.00
Website
https://www.fluoropharma.comCEO
Edward L. Lyons Jr.
Description
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in patients with CAD. The company has license agreements with Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey.
FPMI Financial Timeline
Browse a chronological timeline of FluoroPharma Medical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
FPMI Stock Performance
Access detailed FPMI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.